10x Genomics Appoints Adam Taich as New CFO
Company Announcements

10x Genomics Appoints Adam Taich as New CFO

10x Genomics (TXG) has shared an update.

Adam S. Taich is set to become the new Chief Financial Officer of the Company on August 12, 2024, bringing a wealth of experience from his previous roles at Standard BioTools Inc., SomaLogic, Inc., and ThermoFisher Scientific. He succeeds Justin J. McAnear, who will assist in the transition until August 30. Taich’s compensation package includes a $500,000 annual salary, potential bonuses, stock unit grants, and standard executive benefits. The Company has confirmed there are no undisclosed arrangements or conflicts of interest associated with Taich’s appointment.

For an in-depth examination of TXG stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFly10x Genomics price target lowered to $19 from $21 at Barclays
TheFly10x Genomics’ Visium HD selected by TechBio startup Cure51
TipRanks Auto-Generated Newsdesk10X Genomics CEO Serge Saxonov Initiates Rule 10b5-1 Trading Plan Amid Strategic Financial Maneuvering
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App